17.35 -0.55 (-3.06%)
THRX
| Trade THRX now with |
|
Stock Details
Last Trade:17.35 Change:-0.55 (-3.06%) Prev Close:17.90 Open: 17.99 Days Range:17.27 – 17.99 52 Week Range: 12.91 - 28.95 Volume:361548 P/E: N/AEPS:-1.21
View AllRecent Alerts 02/10/12
Recent Alert on 02/09/12 at 6:46pm
After-Hours Movers 02/09: (SWIR) (LNKD) (UEPS) Higher; (NGSX) (XIDE) (TRLG) (NUAN) Lower
After-Hours Movers 02/09: (SWIR) (LNKD) (UEPS) Higher; (NGSX) (XIDE) (TRLG) (NUAN) Lower
NeurogesX (Nasdaq: NGSX) 25% LOWER; today announced that the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) to the U.S. FDA did not recommend FDA approval of a new indication for Qutenza® (Capsaicin) 8% patch for the... Read More
Recent Alert on 02/09/12 at 4:39pm
Theravance, Inc. (THRX) Reports Q4 Loss of $0.45, Sales Fall Short
Theravance, Inc. (THRX) Reports Q4 Loss of $0.45, Sales Fall Short
Recent Alert on 02/08/12 at 6:04pm
Trading Radar for 02/09: Sirius XM (SIRI), PepsiCo (PEP), Expedia (EXPE), Dunkin' Brands (DNKN), Linkedin (LNKD), Activision (ATVI) Report
Trading Radar for 02/09: Sirius XM (SIRI), PepsiCo (PEP), Expedia (EXPE), Dunkin' Brands (DNKN), Linkedin (LNKD), Activision (ATVI) Report
Recent Alert on 01/31/12 at 6:56am
Morgan Stanley Starts Theravance Inc. (THRX) at Underweight, Sees 38% Downside
Morgan Stanley Starts Theravance Inc. (THRX) at Underweight, Sees 38% Downside
Recent Alert on 01/31/12 at 6:56am
Morgan Stanley Starts Theravance Inc. (THRX) at Underweight, Sees 38% Downside
Morgan Stanley Starts Theravance Inc. (THRX) at Underweight, Sees 38% Downside
View AllRecent Press Releases
Press Release on 02/09/12 at 4:05pm
Theravance Reports Fourth Quarter and Full Year 2011 Financial Results
Theravance Reports Fourth Quarter and Full Year 2011 Financial Results
View AllRecent SEC Filings
View AllRecent Blog Posts
Blog Posts on 01/31/12 at 8:40pm
6 Highly Liquid Biotech Stocks With Positive Correlation To Volatility
6 Highly Liquid Biotech Stocks With Positive Correlation To Volatility